Prime Medicine (PRME) Invested Capital (2021 - 2025)
Historic Invested Capital for Prime Medicine (PRME) over the last 5 years, with Q3 2025 value amounting to $161.8 million.
- Prime Medicine's Invested Capital fell 1460.81% to $161.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $161.8 million, marking a year-over-year decrease of 1460.81%. This contributed to the annual value of $153.1 million for FY2024, which is 1508.82% up from last year.
- According to the latest figures from Q3 2025, Prime Medicine's Invested Capital is $161.8 million, which was down 1460.81% from $60.9 million recorded in Q2 2025.
- In the past 5 years, Prime Medicine's Invested Capital registered a high of $316.3 million during Q4 2022, and its lowest value of -$223.1 million during Q3 2022.
- Moreover, its 5-year median value for Invested Capital was $153.1 million (2024), whereas its average is $84.7 million.
- The largest annual percentage gain for Prime Medicine's Invested Capital in the last 5 years was 30242.58% (2022), contrasted with its biggest fall of 13628.55% (2022).
- Over the past 5 years, Prime Medicine's Invested Capital (Quarter) stood at -$156.2 million in 2021, then soared by 302.43% to $316.3 million in 2022, then crashed by 57.92% to $133.1 million in 2023, then rose by 15.09% to $153.1 million in 2024, then rose by 5.66% to $161.8 million in 2025.
- Its Invested Capital was $161.8 million in Q3 2025, compared to $60.9 million in Q2 2025 and $106.9 million in Q1 2025.